Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.

By D. Neofytos, D. Horn, E. Anaissie, W. Steinbach, A. Olyaei, J. Fishman, M. Pfaller, C. Chang, K. Webster, K. Marr. Clinical Infectious Diseases, 2009

796 citations recorded by the source corpus.

Subfields: Epidemiology, Infectious Diseases, Ophthalmology

View Paper: https://www.semanticscholar.org/paper/4fac8c95ec1bab58437b4f7ff52acbe5eb96052c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

In Infectious Diseases

Citations in the corpus

Epidemiology of Invasive Mycoses in North America (2010, background): “Analysis of the PATH Alliance database for the years 2004 through 2007 revealed 6- and 12-week mortality rates of 21.5% and 35.5%, respectively, among 148 HSCT recipients with IA (Neofytos et al. 2009a).”
Epidemiology and clinical manifestations of mucormycosis. (2012, background): “on transplant patients (TRANSNET) or immunosuppressed patients in general (PATH Alliance), in whom the incidence of mucormycosis may be higher [45].”
Aspergillus fumigatus and Aspergillosis in 2019 (2019, background): “Over the past 2 decades, we have witnessed improved outcomes of patients with IA as a result of better diagnostic and therapeutic modalities (56, 65, 67, 96, 683).”
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. (2018, background): “In fact, up to two-thirds of patients with IA diagnosed after allogeneic HSCT are not neutropenic [167], and the median time of diagnosis of IA after allogeneic HSCT is 82 days (range, 3e6542 days) [168].”
Global trends in the distribution of Candida species causing candidemia. (2014, neutral): “glabrata [32–34].”